NEFL调节NRN1-介导的线粒体通路以促进二甲基氨酸诱导的神经亡
Sensen Zhu1, Liping Su2, Mengjie Zhuang1
1School of Basic Medical Science, Xinjiang Medical University, Urumqi, 830017, China.
Molecular neurobiology
|November 18, 2024
概括
药物滥用会通过诱导神经元亡引起神经系统损伤. 神经纤维光链 (NEFL) 调节神经素1 (NRN1) 和线粒体通路,促进这种细胞死亡.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 毒理学 毒理学 毒理学
背景情况:
- 滥用甲基 (海洛因) 是一个重要的全球社会问题,具有严重的神经后果.
- 亡与神经系统疾病的发病有关.
- 之前的研究表明,在酸甲基摩尔成的老鼠的大脑中,真空状退化和亡增加,但潜在的机制尚不清楚.
研究的目的:
- 阐明二甲基氨酸诱导神经元亡的分子机制.
- 研究神经纤维光链 (NEFL) 和神经素1 (NRN1) 在二甲基甲基胺诱导的神经毒性的作用.
主要方法:
- 采用TMT技术进行了对甲基摩尔成的老鼠大脑组织的蛋白质组分析.
- 使用PC12细胞构建了一个细胞亡模型.
- 使用过度表达和沉默的lentiviral载体来操纵NEFL表达.
- 进行传输电子显微镜 (TEM) 检查细胞超结构.
主要成果:
- 甲基氨酸诱导的亡与线粒体功能障碍有关,包括真空化,扩张,活性氧物种 (ROS) 的增加和线粒体膜潜力的降低.
- 发现NEFL可以调节NRN1的表达,从而影响细胞亡水平.
- 在NEFL表达的变化调节了观察到的线粒体变化.
结论:
- 甲基甲基氨酸通过一个涉及NEFL的机制触发神经元亡.
- NEFL调节NRN1介导的线粒体通路,从而促进细胞亡.
- 这些发现提供了关于二甲酸和潜在治疗点的神经毒性作用的见解.
更多相关视频
09:50Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice
Published on: April 24, 2013
11.7K
10:36Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
8.0K
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
954
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
954
